✦ LIBER ✦

Population-based Study of Biochemical and Survival Outcomes After Permanent 125I Brachytherapy for Low- and Intermediate-risk Prostate Cancer

✍ Scribed by W.J. Morris; M. Keyes; D. Palma; I. Spadinger; M.R. McKenzie; A. Agranovich; T. Pickles; M. Liu; W. Kwan; J. Wu; E. Berthelet; H. Pai

Book ID: 116949604
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 456 KB
Volume: 73
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2008.07.064

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MP-16.12: Survival Free of Disease and C

MP-16.12: Survival Free of Disease and Chronic Toxicity for Localized Prostate Cancer Treated with Low Dose I 125 Permanent Prostate Brachytherapy

✍ A. Rodrı́guez Antolin; J. Duarte Ojeda; J. Romero Otero; J. Medina-Polo; D. Cast 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Timing of biochemical failure and distan

Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy

✍ Peter B. Morgan; Alexandra L. Hanlon; Eric M. Horwitz; Mark K. Buyyounouski; Rob 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 628 KB

## Abstract ## BACKGROUND. The relation of prostate cancer risk‐group stratification and the timing of biochemical failure (BF) and distant metastasis (DM) is not well defined. The authors hypothesized that early failures due to subclinical micrometastasis at presentation could be differentiated f

Long-term biochemical control of prostat

Long-term biochemical control of prostate cancer after standard or hyper-fractionation: Evidence for different outcomes between low–intermediate and high risk patients

✍ Riccardo Valdagni; Alan E. Nahum; Tiziana Magnani; Corrado Italia; Angelo Lancen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Five-year biochemical and clinical outco

Five-year biochemical and clinical outcomes for high-dose-rate and low-dose-rate brachytherapy in the setting of favorable risk prostate cancer

✍ Samuel McGrath; Alvaro A. Martinez; D. Jeffrey Demanes; Michel Ghilezan; Lionel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Comparative analysis of prostate-specifi

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

✍ Peter Grimm; Ignace Billiet; David Bostwick; Adam P. Dicker; Steven Frank; Jos I 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB

Editorial Comment on: Poor Overall Survi

Editorial Comment on: Poor Overall Survival in Septa- and Octogenarian Patients after Radical Prostatectomy and Radiotherapy for Prostate Cancer: A Population-Based Study of 6183 Men

✍ Michael J. Barry 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB